Lopez M - Search Results

1

Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.

Maini CL, Tofani A, Sciuto R, Semprebene A, Cavaliere R, Mottolese M, Benevolo M, Ferranti F, Grandinetti ML, Vici P, Lopez M, Botti C. Maini CL, et al. Among authors: lopez m. J Nucl Med. 1997 Oct;38(10):1546-51. J Nucl Med. 1997. PMID: 9379190 Free article.

2

Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.

Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Botti C, et al. Among authors: lopez m. J Am Coll Surg. 1995 Sep;181(3):202-8. J Am Coll Surg. 1995. PMID: 7670678

3

Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma.

Maini CL, Tofani A, Sciuto R, Carpano S, Crecco M, Manni C, Lopez M. Maini CL, et al. Among authors: lopez m. Clin Nucl Med. 1994 Jul;19(7):607-10. doi: 10.1097/00003072-199407000-00010. Clin Nucl Med. 1994. PMID: 7924102

4

111In-octreotide scintigraphy in small cell lung cancer.

Semprebene A, Ferraironi A, Franciotti G, Venturo I, Giunta S, Lopez M, Maini CL. Semprebene A, et al. Among authors: lopez m. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):108-10. Q J Nucl Med. 1995. PMID: 9002764

5

Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.

Lopez M, Vici P, Di Lauro K, Conti F, Paoletti G, Ferraironi A, Sciuto R, Giannarelli D, Maini CL. Lopez M, et al. J Clin Oncol. 1998 Jan;16(1):86-92. doi: 10.1200/JCO.1998.16.1.86. J Clin Oncol. 1998. PMID: 9440727 Clinical Trial.

6

Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.

Maini CL, Sciuto R, Ferraironi A, Vici P, Tofani A, Festa A, Conti F, Lopez M. Maini CL, et al. Among authors: lopez m. J Nucl Cardiol. 1997 Nov-Dec;4(6):502-8. doi: 10.1016/s1071-3581(97)90008-8. J Nucl Cardiol. 1997. PMID: 9456190

7

Somatostatin receptor imaging in small cell lung cancer using 111In-DTPA-octreotide: a preliminary study.

Maini CL, Tofani A, Venturo I, Pigorini F, Sciuto R, Semprebene A, Boni S, Giunta S, Lopez M. Maini CL, et al. Among authors: lopez m. Nucl Med Commun. 1993 Nov;14(11):962-8. doi: 10.1097/00006231-199311000-00005. Nucl Med Commun. 1993. PMID: 8290168

8

Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment.

Vici P, Ferraironi A, Di Lauro L, Carpano S, Conti F, Belli F, Paoletti G, Maini CL, Lopez M. Vici P, et al. Among authors: lopez m. Clin Ter. 1998 Jan-Feb;149(921):15-20. Clin Ter. 1998. PMID: 9621483 Review.

9

European trials with dexrazoxane in amelioration of doxorubicin and epirubicin-induced cardiotoxicity.

Lopez M, Vici P. Lopez M, et al. Semin Oncol. 1998 Aug;25(4 Suppl 10):55-60. Semin Oncol. 1998. PMID: 9768825 Review.

10

[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].

Conti F, Carpano S, Sergi D, Di Lauro L, Amodio A, Vici P, Abbate MI, Ferranti FR, Viola G, Botti C, Foggi P, Sperduti I, Lopez M. Conti F, et al. Among authors: lopez m. Clin Ter. 2007 Jul-Aug;158(4):331-41. Clin Ter. 2007. PMID: 17953285 Clinical Trial. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,468 results

Search Page

Filters